Volume 3, Issue 1 (2017)                   IEM 2017, 3(1): 9-11 | Back to browse issues page

XML Print

1- Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Abstract:   (6041 Views)
Background: Gram-negative organisms producing Extended-spectrum beta-lactamases (ESBLs) are presented as a global problem. Klebsiella pneumoniae is considered as one of the most important microorganism of this group. The prevalence rate of K. pneumoniae species is increasing, and this increase is higher in the ESBL group, indicating the increase in antibiotic resistance. We must have sufficient knowledge about regional antibiotics resistance in order to monitor the prevalence rate and antimicrobial resistance among the isolates by appropriate treatment. In this regard, the objective of our study was to evaluate antimicrobial susceptibility among K. pneumoniae isolates by E-test method in Khatam ol Anbia hospital during 2015.
Materials and methods: This descriptive cross-sectional study was carried out during 2015.  All clinical samples were collected from intensive care unit (ICU) and general wards of Khatam ol Anbia hospital. All of the K. pneumoniae strains were detected by biochemical and microscopic tests. Antimicrobial susceptibility and minimum inhibitory concentration (MIC) were determined by disk diffusion and E-test methods. Descriptive statistics was used to analyze data.
Results: About 62 K.  pneumoniae strains were isolated from clinical samples of ICU and general wards during one year. Of these, 38 (61.3%) isolates were isolated from intensive care unit, and 24 (38.7%) isolates were isolated from the general wards. In this review, the least resistance was related to colistin (4.8%) and Amikacin (14.5%), respectively, and the most resistance was observed to the antibiotics of ciprofloxacin (66.1%), ceftriaxone (62.9%) and gentamicin (59.7%), respectively. Resistance to imipenem was observed in 38.7% of the isolates.
Conclusion: The current study demonstrates that antibiotic resistance pattern is changing, and resistance to imipenem and colistin is rising, so this should be considered as a serious risk for admitted patients in hospital.  
Full-Text [PDF 371 kb]   (3350 Downloads)    

Received: 2016/11/23 | Accepted: 2016/12/26 | Published: 2017/01/1

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.